Datametrex Officially Enters Beta Phase For Telemedicine App

Datametrex AI (TSXV: DM) is one step closer to offering a full service telemedicine app. The company this morning indicated that its Medi-Call MD subsidiary has entered the beta test stage of its phone app, with a closed beta now being launched for patients.

Datametrex AI's Logo

Select patients are to be enrolled within the beta program, with the first webinar on the application to take place at the end of the month. The firm did not indicate which mobile platform has been selected for beta testing, however both Android and Apple apps are anticipated to be released once testing is complete.

The Medi-Call platform has been designed as a subscription service, enabling patients to reach a doctor through the use of their phone to obtain health services, which is said to include prescriptions. Upon download, users are to enter their medical information as well as their preferred pharmacy location prior to being connected with a doctor. After the visit, any required prescription will be automatically forwarded to their pharmacy of choice.

Commenting on the development, Datametrex CEO Marshall Gunter stated, “Medi-Call app is leveraging advanced technology to help bring accessible, affordable healthcare services to patients with doctors supporting Canadians to take greater ownership of their health and wellness outcomes outside of doctor offices and emergency rooms leading to improved health.”

The Medi-Call app is intended to increase the accessibility of quality healthcare to patients, with the company placing an emphasis on those of whom live in rural or isolation communities, as well as those with limited time, transportation, or mobility.

Datametrex AI last traded at $0.17 on the CSE.


FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Datametrex Secures Exclusive Rights For COVID-19 Saliva Test Kit In Canada, Saudi Arabia

Datametrex AI (TSXV: DM) has secured further test kits for its COVID-19 testing operation. The...

Wednesday, February 3, 2021, 08:05:27 AM

Datametrex Secures Services Agreement Valued At An Estimated $20 Million For Supply Of COVID-19 Test Kits

Datametrex AI Limited (TSXV: DM) released substantial news this morning, revealing that the reason for...

Thursday, September 24, 2020, 09:36:53 AM

Datametrex: Canadian AI Bid Results Expected In Coming Weeks – The Daily Dive

Today on the Daily Dive, we are joined by Marshall Gunter, CEO of Datametrex AI...

Friday, August 13, 2021, 01:30:00 PM

BRIEF: A Glance at Datametrex AI’s Share Structure

Datametrex AI Limited (TSXV: DM) had an excellent trading day yesterday. After an early morning...

Tuesday, December 19, 2017, 08:00:05 AM

Datametrex Posts Q1 Revenue Of $19.0 Million, Net Income Of $9.6 Million

Datametrex AI (TSXV: DM) this morning reported its first quarter 2021 financial results, a quite...

Monday, May 31, 2021, 07:36:54 AM